SCHEMBL5382866

SCHEMBL5382866

Cc1oc(-c2ccccc2)nc1CCOCCCCCBr

nearest known ligand 0.58

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PPARG P37231 16/20 0.58
PPARA Q07869 15/20 0.58
PPARD Q03181 5/20 0.58
KDM4E B2RXH2 1/20 0.51
HRH3 Q9Y5N1 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5856033 0.87 PPARG (0.59) PPARGPPARAPPARDKDM4EHRH3
SCHEMBL5854753 0.85 PPARG (0.57) PPARGPPARAPPARDKDM4EHRH3
SCHEMBL6383881 0.84 HRH3 (0.58) PPARGPPARAPPARDKDM4EHRH3
SCHEMBL4389491 0.81 HRH3 (0.61) PPARGPPARAPPARDKDM4EHRH3
SCHEMBL5365698 0.81 PPARG (0.57) PPARGPPARAPPARDKDM4E
SCHEMBL5371259 0.80 PPARG (0.56) PPARGPPARAPPARDKDM4E
SCHEMBL7084006 0.80 PPARA (0.67) PPARGPPARAPPARDKDM4EHRH3
SCHEMBL5386001 0.79 PPARG (0.55) PPARGPPARAPPARDKDM4E
SCHEMBL6969645 0.79 PPARG (0.67) PPARGPPARAPPARD
SCHEMBL5377398 0.78 PPARG (0.54) PPARGPPARAPPARDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7241784-B2 Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-10 US disclosed
US-7241784-B2 Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-10 US disclosed
US-7241784-B2 Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-10 US disclosed
US-20040087636-A1 Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient ONO PHARMACEUTICAL CO., LTD. 2004-05-06 US disclosed
US-6664281-B1 Oxazol-4-yl-alkoxy- or alkthioxy- functionality; peroxisome proliferator activated receptor regulators ONO PHARMACEUTICAL CO., LTD. (JP) 2003-12-16 US disclosed
EP-1108713-A1 CARBOXYLIC ACID DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2001-06-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040087636-A1 Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient PPARA, PPARG, PPARD PPARG 2/4885PPARA 1/4885PPARD 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.